Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA)
Wt. Tino et al., Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA), HYBRIDOMA, 19(3), 2000, pp. 249-257
Prostate-specific membrane antigen (PSMA) is a 750-amino acid glycoprotein
highly expressed in malignant prostate tissues. PSMA reacts with the murine
monoclonal antibody 7E11.C5, whose binding epitope has been mapped to the
N-terminal of the protein distributed on the cytoplasmic side of the plasma
membrane. We have developed murine monoclonal antibodies specific for extr
acellular epitopes of PSMA, Three of these antibodies-1G9 3C6, and 4D4-disp
lay distinct binding properties consistent with their recognition of confor
mational epitopes within native PSMA, Results indicate this panel of antibo
dies binds to native full-length PSMA, but not to fusion proteins containin
g portions of the linear sequence of the protein. Antibody binding is great
ly reduced upon heat denaturation of native PSMA, and these antibodies do n
ot detect PSMA by Western blot. Immunoprecipitation experiments demonstrate
the ability of each to bind to full-length PSMA as well as PSM', a form of
the protein missing the first 57 amino acids. These results indicate each
antibody is specific for an epitope within the extracellular domain, a regi
on spanning residues 44-750. Flow cytometric experiments indicate strong sp
ecific binding to live LNCaP cells. Antibody inhibition studies demonstrate
that these antibodies recognize at least two distinct epitopes, Taken toge
ther, the results demonstrate that these antibodies are specific for native
protein conformational epitopes within the extracellular domain. Their pro
perties, in particular strong binding to live cancer cells, make them ideal
candidates that are clearly superior to linear sequence epitope specific a
ntibodies for in vivo applications.